262 related articles for article (PubMed ID: 12811971)
1. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
Groeneweg M; Lankester AC; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
[TBL] [Abstract][Full Text] [Related]
2. [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].
Groeneweg M; Hartwig NG; Poerink-Stockschläder AB; Schweizer JJ; Bijleveld CM; Bredius RG
Ned Tijdschr Geneeskd; 2003 May; 147(21):1024-8. PubMed ID: 12811975
[TBL] [Abstract][Full Text] [Related]
3. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
Bajorath J; Seyama K; Nonoyama S; Ochs HD; Aruffo A
Protein Sci; 1996 Mar; 5(3):531-4. PubMed ID: 16509032
[TBL] [Abstract][Full Text] [Related]
4. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.
Rangel-Santos A; Wakim VL; Jacob CM; Pastorino AC; Cunha JM; Collanieri AC; Niemela JE; Grumach AS; Duarte AJ; Moraes-Vasconcelos D; Oliveira JB
Scand J Immunol; 2009 Feb; 69(2):169-73. PubMed ID: 19170966
[TBL] [Abstract][Full Text] [Related]
6. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
7. The X-linked hyperimmunoglobulin M syndrome.
Fuleihan RL
Semin Hematol; 1998 Oct; 35(4):321-31. PubMed ID: 9801261
[TBL] [Abstract][Full Text] [Related]
8. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
Agematsu K; Nagumo H; Shinozaki K; Hokibara S; Yasui K; Terada K; Kawamura N; Toba T; Nonoyama S; Ochs HD; Komiyama A
J Clin Invest; 1998 Aug; 102(4):853-60. PubMed ID: 9710455
[TBL] [Abstract][Full Text] [Related]
9. [Type 1 hyper-IgM syndrome diagnosed in a 28-year-old patient with recurrent infections since childhood].
Koike M; Oshimi K; Agematu K; Futani T
Rinsho Ketsueki; 2006 Oct; 47(10):1377-80. PubMed ID: 17094577
[TBL] [Abstract][Full Text] [Related]
10. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome.
Kato T; Tsuge I; Inaba J; Kato K; Matsuyama T; Kojima S
Bone Marrow Transplant; 1999 May; 23(10):1081-3. PubMed ID: 10373076
[TBL] [Abstract][Full Text] [Related]
11. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.
Prasad ML; Velickovic M; Weston SA; Benson EM
J Clin Pathol; 2005 Jan; 58(1):90-2. PubMed ID: 15623492
[TBL] [Abstract][Full Text] [Related]
12. Characterization of soluble CD40 ligand released from human activated platelets.
Jin Y; Nonoyama S; Morio T; Imai K; Ochs HD; Mizutani S
J Med Dent Sci; 2001 Mar; 48(1):23-7. PubMed ID: 12160239
[TBL] [Abstract][Full Text] [Related]
13. Hyper-IgM syndrome: a case report.
Wang IJ; Wang SJ; Yan DC; Lin SJ; Chiang BL
J Microbiol Immunol Infect; 2003 Sep; 36(3):215-7. PubMed ID: 14582569
[TBL] [Abstract][Full Text] [Related]
14. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
15. Localization of the genetic defect in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1) to the CD40 ligand gene.
Fuleihan R; Ramesh N; Rosen FS; Geha RS
Trans Assoc Am Physicians; 1993; 106():91-5. PubMed ID: 7518624
[No Abstract] [Full Text] [Related]
16. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
Seyama K; Osborne WR; Ochs HD
J Biol Chem; 1999 Apr; 274(16):11310-20. PubMed ID: 10196221
[TBL] [Abstract][Full Text] [Related]
18. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
19. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
[TBL] [Abstract][Full Text] [Related]
20. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM.
Hayward AR; Levy J; Facchetti F; Notarangelo L; Ochs HD; Etzioni A; Bonnefoy JY; Cosyns M; Weinberg A
J Immunol; 1997 Jan; 158(2):977-83. PubMed ID: 8993019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
